Global Recombinant Human Insulin Market Insights, Forecast to 2029

Global Recombinant Human Insulin Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Recombinant Human Insulin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 by Recombinant DNA Technology Using Fermentation in Bacteria Way
1.2.3 by Recombinant DNA Technology Using Fermentation in Yeast Way
1.3 Market by Application
1.3.1 Global Recombinant Human Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Type 1 Diabetes Mellitus
1.3.3 Type 2 Diabetes Mellitus
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Insulin Sales Estimates and Forecasts 2018-2029
2.2 Global Recombinant Human Insulin Revenue by Region
2.2.1 Global Recombinant Human Insulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Recombinant Human Insulin Revenue by Region (2018-2023)
2.2.3 Global Recombinant Human Insulin Revenue by Region (2024-2029)
2.2.4 Global Recombinant Human Insulin Revenue Market Share by Region (2018-2029)
2.3 Global Recombinant Human Insulin Sales Estimates and Forecasts 2018-2029
2.4 Global Recombinant Human Insulin Sales by Region
2.4.1 Global Recombinant Human Insulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Recombinant Human Insulin Sales by Region (2018-2023)
2.4.3 Global Recombinant Human Insulin Sales by Region (2024-2029)
2.4.4 Global Recombinant Human Insulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Insulin Sales by Manufacturers
3.1.1 Global Recombinant Human Insulin Sales by Manufacturers (2018-2023)
3.1.2 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Insulin in 2022
3.2 Global Recombinant Human Insulin Revenue by Manufacturers
3.2.1 Global Recombinant Human Insulin Revenue by Manufacturers (2018-2023)
3.2.2 Global Recombinant Human Insulin Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2022
3.3 Global Key Players of Recombinant Human Insulin, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Recombinant Human Insulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Insulin Sales by Type
4.1.1 Global Recombinant Human Insulin Historical Sales by Type (2018-2023)
4.1.2 Global Recombinant Human Insulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Recombinant Human Insulin Sales Market Share by Type (2018-2029)
4.2 Global Recombinant Human Insulin Revenue by Type
4.2.1 Global Recombinant Human Insulin Historical Revenue by Type (2018-2023)
4.2.2 Global Recombinant Human Insulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
4.3 Global Recombinant Human Insulin Price by Type
4.3.1 Global Recombinant Human Insulin Price by Type (2018-2023)
4.3.2 Global Recombinant Human Insulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Recombinant Human Insulin Sales by Application
5.1.1 Global Recombinant Human Insulin Historical Sales by Application (2018-2023)
5.1.2 Global Recombinant Human Insulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Recombinant Human Insulin Sales Market Share by Application (2018-2029)
5.2 Global Recombinant Human Insulin Revenue by Application
5.2.1 Global Recombinant Human Insulin Historical Revenue by Application (2018-2023)
5.2.2 Global Recombinant Human Insulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
5.3 Global Recombinant Human Insulin Price by Application
5.3.1 Global Recombinant Human Insulin Price by Application (2018-2023)
5.3.2 Global Recombinant Human Insulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Recombinant Human Insulin Market Size by Type
6.1.1 US & Canada Recombinant Human Insulin Sales by Type (2018-2029)
6.1.2 US & Canada Recombinant Human Insulin Revenue by Type (2018-2029)
6.2 US & Canada Recombinant Human Insulin Market Size by Application
6.2.1 US & Canada Recombinant Human Insulin Sales by Application (2018-2029)
6.2.2 US & Canada Recombinant Human Insulin Revenue by Application (2018-2029)
6.3 US & Canada Recombinant Human Insulin Market Size by Country
6.3.1 US & Canada Recombinant Human Insulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Recombinant Human Insulin Sales by Country (2018-2029)
6.3.3 US & Canada Recombinant Human Insulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Insulin Market Size by Type
7.1.1 Europe Recombinant Human Insulin Sales by Type (2018-2029)
7.1.2 Europe Recombinant Human Insulin Revenue by Type (2018-2029)
7.2 Europe Recombinant Human Insulin Market Size by Application
7.2.1 Europe Recombinant Human Insulin Sales by Application (2018-2029)
7.2.2 Europe Recombinant Human Insulin Revenue by Application (2018-2029)
7.3 Europe Recombinant Human Insulin Market Size by Country
7.3.1 Europe Recombinant Human Insulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Recombinant Human Insulin Sales by Country (2018-2029)
7.3.3 Europe Recombinant Human Insulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Insulin Market Size
8.1.1 China Recombinant Human Insulin Sales (2018-2029)
8.1.2 China Recombinant Human Insulin Revenue (2018-2029)
8.2 China Recombinant Human Insulin Market Size by Application
8.2.1 China Recombinant Human Insulin Sales by Application (2018-2029)
8.2.2 China Recombinant Human Insulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Recombinant Human Insulin Market Size by Type
9.1.1 Asia Recombinant Human Insulin Sales by Type (2018-2029)
9.1.2 Asia Recombinant Human Insulin Revenue by Type (2018-2029)
9.2 Asia Recombinant Human Insulin Market Size by Application
9.2.1 Asia Recombinant Human Insulin Sales by Application (2018-2029)
9.2.2 Asia Recombinant Human Insulin Revenue by Application (2018-2029)
9.3 Asia Recombinant Human Insulin Sales by Region
9.3.1 Asia Recombinant Human Insulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Recombinant Human Insulin Revenue by Region (2018-2029)
9.3.3 Asia Recombinant Human Insulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Akron Biotech
11.1.1 Akron Biotech Company Information
11.1.2 Akron Biotech Overview
11.1.3 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Akron Biotech Recent Developments
11.2 Wockhardt
11.2.1 Wockhardt Company Information
11.2.2 Wockhardt Overview
11.2.3 Wockhardt Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Wockhardt Recent Developments
11.3 Dance Biopharm
11.3.1 Dance Biopharm Company Information
11.3.2 Dance Biopharm Overview
11.3.3 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dance Biopharm Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Gan & Lee
11.5.1 Gan & Lee Company Information
11.5.2 Gan & Lee Overview
11.5.3 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Gan & Lee Recent Developments
11.6 United Laboratories
11.6.1 United Laboratories Company Information
11.6.2 United Laboratories Overview
11.6.3 United Laboratories Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 United Laboratories Recent Developments
11.7 Dongbro Pharmaceuticri
11.7.1 Dongbro Pharmaceuticri Company Information
11.7.2 Dongbro Pharmaceuticri Overview
11.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dongbro Pharmaceuticri Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Insulin Industry Chain Analysis
12.2 Recombinant Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Insulin Production Mode & Process
12.4 Recombinant Human Insulin Sales and Marketing
12.4.1 Recombinant Human Insulin Sales Channels
12.4.2 Recombinant Human Insulin Distributors
12.5 Recombinant Human Insulin Customers
13 Market Dynamics
13.1 Recombinant Human Insulin Industry Trends
13.2 Recombinant Human Insulin Market Drivers
13.3 Recombinant Human Insulin Market Challenges
13.4 Recombinant Human Insulin Market Restraints
14 Key Findings in The Global Recombinant Human Insulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of Type II
Table 4. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Recombinant Human Insulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Recombinant Human Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Recombinant Human Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Recombinant Human Insulin Revenue Market Share by Region (2018-2023)
Table 9. Global Recombinant Human Insulin Revenue Market Share by Region (2024-2029)
Table 10. Global Recombinant Human Insulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Recombinant Human Insulin Sales by Region (2018-2023) & (g)
Table 12. Global Recombinant Human Insulin Sales by Region (2024-2029) & (g)
Table 13. Global Recombinant Human Insulin Sales Market Share by Region (2018-2023)
Table 14. Global Recombinant Human Insulin Sales Market Share by Region (2024-2029)
Table 15. Global Recombinant Human Insulin Sales by Manufacturers (2018-2023) & (g)
Table 16. Global Recombinant Human Insulin Sales Share by Manufacturers (2018-2023)
Table 17. Global Recombinant Human Insulin Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Recombinant Human Insulin Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Recombinant Human Insulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Recombinant Human Insulin Price by Manufacturers 2018-2023 (USD/mg)
Table 21. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2022)
Table 23. Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application
Table 25. Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 28. Global Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 29. Global Recombinant Human Insulin Sales Share by Type (2018-2023)
Table 30. Global Recombinant Human Insulin Sales Share by Type (2024-2029)
Table 31. Global Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Recombinant Human Insulin Revenue Share by Type (2018-2023)
Table 34. Global Recombinant Human Insulin Revenue Share by Type (2024-2029)
Table 35. Recombinant Human Insulin Price by Type (2018-2023) & (USD/mg)
Table 36. Global Recombinant Human Insulin Price Forecast by Type (2024-2029) & (USD/mg)
Table 37. Global Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 38. Global Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 39. Global Recombinant Human Insulin Sales Share by Application (2018-2023)
Table 40. Global Recombinant Human Insulin Sales Share by Application (2024-2029)
Table 41. Global Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Recombinant Human Insulin Revenue Share by Application (2018-2023)
Table 44. Global Recombinant Human Insulin Revenue Share by Application (2024-2029)
Table 45. Recombinant Human Insulin Price by Application (2018-2023) & (USD/mg)
Table 46. Global Recombinant Human Insulin Price Forecast by Application (2024-2029) & (USD/mg)
Table 47. US & Canada Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 48. US & Canada Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 49. US & Canada Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 52. US & Canada Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 53. US & Canada Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Recombinant Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Recombinant Human Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Recombinant Human Insulin Sales by Country (2018-2023) & (g)
Table 59. US & Canada Recombinant Human Insulin Sales by Country (2024-2029) & (g)
Table 60. Europe Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 61. Europe Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 62. Europe Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 65. Europe Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 66. Europe Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Recombinant Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Recombinant Human Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Recombinant Human Insulin Sales by Country (2018-2023) & (g)
Table 72. Europe Recombinant Human Insulin Sales by Country (2024-2029) & (g)
Table 73. China Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 74. China Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 75. China Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 78. China Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 79. China Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 82. Asia Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 83. Asia Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 86. Asia Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 87. Asia Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Recombinant Human Insulin Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Recombinant Human Insulin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Recombinant Human Insulin Sales by Region (2018-2023) & (g)
Table 93. Asia Recombinant Human Insulin Sales by Region (2024-2029) & (g)
Table 94. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2018-2023) & (g)
Table 95. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2024-2029) & (g)
Table 96. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2018-2023) & (g)
Table 99. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2024-2029) & (g)
Table 100. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2018-2023) & (g)
Table 106. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2024-2029) & (g)
Table 107. Akron Biotech Company Information
Table 108. Akron Biotech Description and Major Businesses
Table 109. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 110. Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Akron Biotech Recent Developments
Table 112. Wockhardt Company Information
Table 113. Wockhardt Description and Major Businesses
Table 114. Wockhardt Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 115. Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Wockhardt Recent Developments
Table 117. Dance Biopharm Company Information
Table 118. Dance Biopharm Description and Major Businesses
Table 119. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 120. Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dance Biopharm Recent Developments
Table 122. Novo Nordisk Company Information
Table 123. Novo Nordisk Description and Major Businesses
Table 124. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 125. Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novo Nordisk Recent Developments
Table 127. Gan & Lee Company Information
Table 128. Gan & Lee Description and Major Businesses
Table 129. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 130. Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Gan & Lee Recent Developments
Table 132. United Laboratories Company Information
Table 133. United Laboratories Description and Major Businesses
Table 134. United Laboratories Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 135. United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. United Laboratories Recent Developments
Table 137. Dongbro Pharmaceuticri Company Information
Table 138. Dongbro Pharmaceuticri Description and Major Businesses
Table 139. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2023)
Table 140. Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Dongbro Pharmaceuticri Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Recombinant Human Insulin Distributors List
Table 145. Recombinant Human Insulin Customers List
Table 146. Recombinant Human Insulin Market Trends
Table 147. Recombinant Human Insulin Market Drivers
Table 148. Recombinant Human Insulin Market Challenges
Table 149. Recombinant Human Insulin Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Insulin Product Picture
Figure 2. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Recombinant Human Insulin Market Share by Type in 2022 & 2029
Figure 4. Type I Product Picture
Figure 5. Type II Product Picture
Figure 6. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Recombinant Human Insulin Market Share by Application in 2022 & 2029
Figure 8. Type 1 Diabetes Mellitus
Figure 9. Type 2 Diabetes Mellitus
Figure 10. Recombinant Human Insulin Report Years Considered
Figure 11. Global Recombinant Human Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Recombinant Human Insulin Revenue 2018-2029 (US$ Million)
Figure 13. Global Recombinant Human Insulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2018-2029)
Figure 15. Global Recombinant Human Insulin Sales 2018-2029 ((g)
Figure 16. Global Recombinant Human Insulin Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Recombinant Human Insulin Sales YoY (2018-2029) & (g)
Figure 18. US & Canada Recombinant Human Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Recombinant Human Insulin Sales YoY (2018-2029) & (g)
Figure 20. Europe Recombinant Human Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Recombinant Human Insulin Sales YoY (2018-2029) & (g)
Figure 22. China Recombinant Human Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Recombinant Human Insulin Sales YoY (2018-2029) & (g)
Figure 24. Asia (excluding China) Recombinant Human Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Recombinant Human Insulin Sales YoY (2018-2029) & (g)
Figure 26. Middle East, Africa and Latin America Recombinant Human Insulin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Recombinant Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Recombinant Human Insulin in the World: Market Share by Recombinant Human Insulin Revenue in 2022
Figure 29. Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Recombinant Human Insulin Sales Market Share by Type (2018-2029)
Figure 31. Global Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
Figure 32. Global Recombinant Human Insulin Sales Market Share by Application (2018-2029)
Figure 33. Global Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Recombinant Human Insulin Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Recombinant Human Insulin Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Recombinant Human Insulin Revenue Share by Country (2018-2029)
Figure 39. US & Canada Recombinant Human Insulin Sales Share by Country (2018-2029)
Figure 40. U.S. Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Recombinant Human Insulin Sales Market Share by Type (2018-2029)
Figure 43. Europe Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
Figure 44. Europe Recombinant Human Insulin Sales Market Share by Application (2018-2029)
Figure 45. Europe Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
Figure 46. Europe Recombinant Human Insulin Revenue Share by Country (2018-2029)
Figure 47. Europe Recombinant Human Insulin Sales Share by Country (2018-2029)
Figure 48. Germany Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 49. France Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 53. China Recombinant Human Insulin Sales Market Share by Type (2018-2029)
Figure 54. China Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
Figure 55. China Recombinant Human Insulin Sales Market Share by Application (2018-2029)
Figure 56. China Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
Figure 57. Asia Recombinant Human Insulin Sales Market Share by Type (2018-2029)
Figure 58. Asia Recombinant Human Insulin Revenue Market Share by Type (2018-2029)
Figure 59. Asia Recombinant Human Insulin Sales Market Share by Application (2018-2029)
Figure 60. Asia Recombinant Human Insulin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Recombinant Human Insulin Revenue Share by Region (2018-2029)
Figure 62. Asia Recombinant Human Insulin Sales Share by Region (2018-2029)
Figure 63. Japan Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Recombinant Human Insulin Revenue (2018-2029) & (US$ Million)
Figure 67. India Rec

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......

Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154

According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......

Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......

Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Next Generation Sequencing - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......

Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......

Global Genotyping Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128

Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......

Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs